CVAC
|CureVac NV
NASDAQ
USD 4.41
-0.05|-1.12%
Current Price
USD 4.41
Change
USD -0.05 (-1.12%)
P/E Ratio
5.09
Dividend Yield
Market Cap
1.04B
Volume
300,783
Open
USD 4.43
Previous Close
USD 4.46
52-Week High
USD 5.28
52-Week Low
USD 2.37
About CureVac NV
CureVac N.V., a biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). The company's portfolio includes clinical and preclinical candidates for various disease indications in prophylactic vaccines, oncology, and molecular therapy. It also delivers optimized mRNAs to stimulate the production of therapeutic proteins utilizing its technology and instructs human cells to produce or secrete specific proteins in the nucleus, cytopl...
Sector:Healthcare
Industry:Biotechnology
CEO:Dr. Alexander Zehnder M.B.A., M.D.
Employees:825
Headquarters:Tübingen, Germany
Website:www.curevac.com
Dividend History
Dividend Payments
| Declared Date | Record Date | Payment Date | Amount | Frequency |
|---|
Similar Companies
Explore Stocks by Sector
technology
finance
healthcare
Frequently Asked Questions